BRCA-MUTATED OVARIAN CARCINOMA
Clinical trials for BRCA-MUTATED OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BRCA-MUTATED OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for BRCA-MUTATED OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early-phase trial is testing the drug olaparib in 15 people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer. Participants take olaparib for two cycles before their planned surgery to see if it can shrink tumors and is safe. The goal is to find …
Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
Can family testing prevent ovarian cancer? new study tracks who gets screened
Knowledge-focused OngoingThis study tracks how often family members of ovarian cancer patients with certain gene mutations (like BRCA) get tested themselves. The goal is to see if 'cascade testing' helps find more people at risk, so they can take steps to prevent cancer. About 118 patients and their rela…
Matched conditions: BRCA-MUTATED OVARIAN CARCINOMA
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated May 26, 2026 10:07 UTC